Distinct dendritic cell subsets are associated with immune dysfunction and clinical severity in sickle cell anemia

Area of Science:

• Immunology
• Hematology
• Cell Biology

Background:

• Sickle cell anemia (SCA) involves chronic hemolysis, inflammation, and immune dysfunction, with dendritic cells (DCs) playing a key role.
• Limited understanding of DC subset characteristics and clinical relevance in SCA necessitates further investigation.

Purpose of the Study:

• To comprehensively characterize circulating DC and monocyte subsets in SCA patients.
• To integrate immunophenotypic data with clinical parameters and T-cell responses.
• To elucidate the role of DC subsets in SCA immunopathogenesis and disease severity.

Main Methods:

• In-depth immunophenotypic analysis of circulating DC and monocyte subsets in SCA patients.
• Integration of data on DC activation status, immunoregulatory molecules, T-cell phenotypes, and systemic cytokines.
• Correlation analysis with hematological and biochemical parameters of disease severity.

Main Results:

• Expansion of activated type 2 conventional DCs (cDC2), inflammatory DCs (iDCs), and plasmacytoid DCs (pDCs); reduction in type 1 cDCs (cDC1).
• Activation of cDC2 and iDCs correlated with disease severity markers; pDC, transitional DC (tDC), and cDC1 activation linked to milder clinical profiles.
• Upregulation of heme oxygenase-1 in multiple DC subsets; pDC/tDC activation associated with T-cell IFN-γ/IL-17 production; cDC1 frequency linked to regulatory T-cell expansion.

Conclusions:

• Distinct DC and monocyte subset signatures are associated with SCA clinical severity.
• DC subset profiles provide insights into adaptive immune responses and inflammation in SCA.
• Findings highlight novel targets for understanding and potentially treating SCA immunopathogenesis.